N

NEVRO Corp

NVRO

9.19000
USD
-0.74
(-7.45%)
Market Open
Volume
1,287
EPS
0
Div Yield
0
P/E
-3
Market Cap
211,768,372
Related Instruments
A
ABMD
0
(0%)
0.000000 USD
BSX
1.315
(1.78%)
75.170 USD
C
COO
0.880
(0.94%)
94.200 USD
EW
-1.220
(-1.94%)
61.830 USD
ISRG
6.98
(1.57%)
451.27 USD
MDT
0.160
(0.20%)
80.470 USD
P
PODD
2.950
(1.52%)
197.390 USD
SYK
5.59
(1.71%)
332.94 USD
T
TNDM
-1.800
(-4.87%)
35.170 USD
Z
ZBH
-0.280
(-0.25%)
111.100 USD
News

Title: NEVRO Corp

Sector: Healthcare
Industry: Medical Devices
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.